中国经济网北京9月17日讯 晶华微(688130.SH)日前披露2025年半年度报告。 （责任编辑：魏京婷） | | | | | 单位:元 币种:人民币 | | --- | --- | --- | --- | --- | | 主要会计数据 | 2024年 | 2023年 | 本期比上 年同期增 | 2022年 | | | | | 減(%) | | | 营业收入 | 134.845.663.80 | 126.805.482.06 | 6.34 | 111.043.287.25 | | 扣除与主营业务无 关的业务收入和不 | 134.845.663.80 | 126.805.482.06 | 6.34 | 110,309,944.57 | | 具备商业实质的收 | | | | | | 入后的营业收入 | | | | | | 归属于上市公司股 | -10.270.082.81 | -20.350.966.15 | 不適用 | 22.125.087.12 | | 东的净利润 | | | | | | 归属于上市公司股 东的扣除非经常性 | -27.760.823.18 | -35.102.089.01 | 不适用 | ...

Summary of Key Points Core Viewpoint - The company intends to use part of the raised funds to provide loans to its wholly-owned subsidiary, Shenzhen Jinghua Zhixin Microelectronics Co., Ltd., to implement its fundraising projects, which aligns with its overall strategic planning and long-term interests [1][8]. Fundraising Basic Situation - The company raised a total of RMB 1,047,987,200.00 by issuing 16.64 million shares at RMB 62.98 per share, with a net amount of RMB 920,537,016.65 after deducting issuance costs [1][2]. Management and Use of Raised Funds - All raised funds have been deposited into a special account approved by the board of directors, and a tripartite supervision agreement has been signed with the sponsor and the supervising bank [2][9]. Fundraising Project Adjustments - The company has made adjustments to its fundraising projects, including extending the implementation period for certain projects to July 2027 and terminating others, such as the "High Precision PGA/ADC Signal Chain Chip Upgrade and Industrialization Project" [3][5]. Loan Provision Details - The company plans to provide a loan of up to RMB 35 million to its subsidiary, Jinghua Zhixin, to ensure the smooth implementation of the "Research and Development Center Construction Project" [5][6]. Loan Management and Usage - The loan will be managed in a dedicated account and can only be used for the specified fundraising projects, with the interest rate based on the latest one-year Loan Prime Rate (LPR) [6][9]. Approval Process - The board of directors approved the loan provision on July 29, 2025, and this decision falls within the board's authority, thus not requiring shareholder approval [7][9]. Sponsor's Verification Opinion - The sponsor has verified that the loan provision complies with relevant regulations and does not harm the interests of the company or its shareholders, ensuring that the fundraising plan remains intact [9][10].

Group 1 - The company is holding its first extraordinary general meeting of shareholders in 2025 to discuss various proposals, including the extension, termination, and addition of implementation content for fundraising projects [1][7] - The meeting will take place on July 29, 2025, at 14:00 in the company's conference room, with both on-site and online voting options available [6][14] - Shareholders and their representatives are required to register 30 minutes before the meeting and must present identification to participate in the voting process [2][3] Group 2 - The company plans to adjust its fundraising project timelines due to market conditions, including a slowdown in the semiconductor market and changes in customer demand [11][12] - The company has decided to terminate the "High-Precision PGA/ADC Signal Chain Chip Upgrade and Industrialization Project" due to unfavorable market conditions and the need to allocate resources more effectively [20][21] - The remaining funds from the terminated project will be kept in a special account and used for new projects that align with the company's strategic goals [22][30] Group 3 - The company intends to increase the implementation content of the "R&D Center Construction Project" to enhance its capabilities in mixed-signal SoC chip products and applications [23][26] - The company is focusing on developing smart home control chips as part of its strategic deployment in response to market trends and government policies promoting smart home technologies [28][29] - The adjustments made to the project are expected to optimize resource allocation and ensure the smooth implementation of fundraising projects without negatively impacting the company's operations [29][30] Group 4 - The company is proposing changes to its registered capital and profit distribution policy, as well as the cancellation of the supervisory board, to align with its operational needs and legal requirements [30][31] - The registered capital will be adjusted following the completion of the 2023 restricted stock incentive plan, increasing the total share capital significantly [31]

7月11日晚间，杭州晶华微电子股份有限公司(以下简称"晶华微"，股票代码"688130.SH")发布公告，拟 将"智慧健康医疗ASSP芯片升级及产业化项目""工控仪表芯片升级及产业化项目""研发中心建设项 目"实施期限延长至2027年7月份，并拟终止"高精度PGA/ADC等模拟信号链芯片升级及产业化项目"。 晶华微公告中解释称，本次调整符合晶华微发展规划及实际需要，有助于提高募集资金使用效率，进一 步提升公司的核心竞争力和盈利能力，实现公司的持续稳定发展。 对于终止项目剩余的募集资金，仍将存放于原募集资金专用账户并做好募集资金管理，延期项目则继续 推进。同时公司将尽快寻找盈利能力较强且有发展前景的新项目，合理使用剩余的募集资金。 项目变动的背后，其实体现着晶华微经营策略的调整，主动聚焦核心业务。 2024年以来，受宏观环境复杂、终端需求结构性下滑、市场竞争加剧等复杂因素影响，多家上市公司的 毛利率下降，半导体行业进入深度转型调整期，企业的战略定力与应变能力愈发受到考验。 项目变动背后：顺应市场审慎决策 近年来，半导体市场经历了深刻的周期性调整，需求结构性下滑明显，全球消费电子市场需求疲软，给 半导体行业带来持 ...

Fundraising Overview - The company raised a total of RMB 1,047,987,200.00 from the issuance of 16.64 million shares at a price of RMB 62.98 per share, with a net amount of RMB 920,537,016.65 after deducting issuance costs [1][2] - All raised funds have been deposited into a special account approved by the board of directors, and a tripartite supervision agreement has been signed with the sponsor and the supervising bank [2] Project Status - As of May 31, 2025, the company has invested RMB 19,993.20 million in the "Smart Health Medical ASSP Chip Upgrade and Industrialization Project," which represents 26.66% of the planned investment of RMB 75,000.00 million [2] - The company has been using its own funds and acceptance bills to pay for project-related expenses, with plans to replace these with raised funds in subsequent quarters [2] Project Delays - The company plans to adjust the expected completion dates for its fundraising projects due to the semiconductor market's cyclical adjustments and structural demand declines, as well as the rapid technological iterations in the industry [4][22] - The company has decided to delay the purchase of office space due to the overall downturn in the real estate market since 2022, opting to conduct project research and development in existing facilities [5] Project Necessity and Feasibility - The "Smart Health Medical ASSP Chip Upgrade and Industrialization Project" is deemed necessary due to the increasing importance of national health and the government's strategic push for health initiatives [6] - The project aligns with national policies promoting the health industry and is supported by local government initiatives, creating favorable conditions for implementation [6][12] Termination of Project - The "High-Precision PGA/ADC Signal Chain Chip Upgrade and Industrialization Project" is proposed to be terminated due to the unfavorable market conditions and the high competition in the semiconductor industry [13][14] - The remaining funds of RMB 15,284.06 million from the terminated project will be kept in the special account and used for new projects with strong profitability and growth potential [16] Adjustments to Project Implementation - The company plans to increase the scope of the "R&D Center Construction Project" to include the development of smart home control chips, reflecting a strategic shift towards the smart home market [19][20] - The implementation will now involve a wholly-owned subsidiary, Shenzhen Jinghua Zhixin Microelectronics Co., Ltd., to optimize resource allocation and ensure project success [17][19] Regulatory Compliance - The adjustments to the fundraising projects have been approved by the board and supervisory committee and will be submitted for shareholder approval, ensuring compliance with relevant regulations [21][24] - The company emphasizes that these changes will not adversely affect its normal operations or shareholder interests, aligning with its long-term strategic goals [22][23]